Investigation on bronchoalveolar lavage technique as an evaluation of drug migration to lung tissue - Investigation on bronchoalveolar lavage technique as an evaluation of drug migration to lung tissue

Medical Co. LTA Clinical Pharmacology Center0 个研究点目标入组 6 人开始时间: 2014年1月18日最近更新: 2023年10月17日

试验速览

暂无简介。

•1, Subject who has allergy or had hypersensitivity to lidocaine and/or azithromycin hydrate. And/or subject with illness which prohibits administration of these substances. 2, Subject with history of drug allergy. 3, Subject who received medical treatment 2 months prior to BAL. 4, Subject who donated more than 400ml or 200ml of blood within 3 months or 1 month prior to BAL, respectively. 5, Subject whose result of screening examinations (include vital sign, 12-lead ECG, and safety laboratory tests) deviates from reference range, and the deviation is judged clinically significant by study physician. 6, Subject who takes drug habitually and/or who abuses alcoholic beverage. 7, Subject who acquired severe medical illness within 4 months prior to BAL. 8, Subject with positive test results of syphilis, HIV antigen/antibody, HBs antigen, and/or HCV antibody. Or subject with sign of infection. 9, Subject who smokes within 6 months prior to BAL. 10, Subject who are considered to be inadequate for this study by study physician.

发起方

Medical Co. LTA Clinical Pharmacology Center